APA

Welters M. J., Braakhuis B. J., Jacobs-Bergmans A. J., Kegel A., Baan R. A., van der Vijgh W. J. & Fichtinger-Schepman A. M. (19990429). The potential of plantinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Welters M J, Braakhuis B J, Jacobs-Bergmans A J, Kegel A, Baan R A, van der Vijgh W J and Fichtinger-Schepman A M. 19990429. The potential of plantinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Welters M. J., Braakhuis B. J., Jacobs-Bergmans A. J., Kegel A., Baan R. A., van der Vijgh W. J. and Fichtinger-Schepman A. M. (19990429). The potential of plantinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Welters M J, Braakhuis B J, Jacobs-Bergmans A J, Kegel A, Baan R A, van der Vijgh W J and Fichtinger-Schepman A M. The potential of plantinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy. : Annals of oncology : official journal of the European Society for Medical Oncology. 19990429.